Marco Taddio
mtaddio@mednet.ucla.edu
Bio:
Marco received his doctorate in 2019 at ETH Zurich and came to the United States to work as a postdoctoral researcher in the group of Prof. Johannes Czernin. He has a strong interest in translational oncology and immunology. His expertise covers a broad field of preclinical research from organic chemistry, over various in vitro techniques to radiolabeling and in vivo studies. He currently focuses on investigating the efficacy and immunological consequences of novel radionuclide therapy approaches, and how to exploit these effects by the combination with immunotherapeutic treatments.